genedrive plc (LON:GDR – Get Free Report) traded down 10% during trading on Friday . The company traded as low as GBX 0.98 and last traded at GBX 1.08. 10,208,916 shares changed hands during trading, an increase of 65% from the average daily volume of 6,194,629 shares. The stock had previously closed at GBX 1.20.
genedrive Price Performance
The company has a current ratio of 0.99, a quick ratio of 5.52 and a debt-to-equity ratio of -120.48. The firm’s 50-day moving average price is GBX 1.22 and its two-hundred day moving average price is GBX 1.08. The stock has a market cap of £17.34 million, a PE ratio of -1.37 and a beta of 0.99.
genedrive Company Profile
ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.
Featured Articles
- Five stocks we like better than genedrive
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.
